Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
| Contact | Wendy Slatery | FOR IMMEDIATE RELEASE |
| Telephone | 913-742-4456 | Sept. 26, 2016 |
| [email protected] | ||
Olathe, Kan., Sept. 26, 2016 -- The NTrainer System by Innara Health has been named an Innovative Technology by Vizient, Inc., and will be exhibited at the Vizient Innovative Technology Exchange Sept. 29 in Dallas. The NTrainer System is an FDA-cleared solution that assesses and develops non-nutritive suck (NNS) in infants and newborns born prematurely.
The expo attracts more than 2,000 clinicians from across the United States to learn about new technologies that improve clinical outcomes, enhance safety or drive improvements to the health care business model.
“It’s an honor for the NTrainer to be named an Innovative Technology and an exciting opportunity to bring unique solutions to the Vizient membership,” said Michael Peck, president and CEO of Innara Health. “We are eager to show the clinicians in attendance how the NTrainer System can help them shorten length of stay (LOS) for premature infants in the NICU, improving clinical efficiency and patient outcomes at their hospitals.”
At the event, Innara will have the opportunity to demonstrate its solution for clinicians and hospital executives, and present clinical evidence in support of its technology, including the recently released study that showed use of the NTrainer System to provide patterned oral stimulation resulted in significant reduction in LOS in preterm infants.
Vizient is the largest member-owned health care company in the country with a diverse membership and customer base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers.
# # #
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
